Literature DB >> 19434840

Search for novel aminoglycosides by combining fragment-based virtual screening and 3D-QSAR scoring.

Piotr Setny1, Joanna Trylska.   

Abstract

<span class="Chemical">Aminoglycosidesn> are antibiotics targeting the 16S RNA A site of the bacterial ribosome. There have been many efforts directed toward design of their synthetic derivatives, however with only few successes. As RNA binders, <span class="Chemical">aminoglycosides are also a difficult target for computational drug design, since most of the existing methods were developed for protein ligands. Here, we present an approach that allows for evading the problems related to still poorly developed RNA docking and scoring algorithms. It is aimed at identification of new molecular scaffolds potentially binding to the A site. The considered molecules are based on the <span class="Chemical">neamine core, which is common for all aminoglycosides and provides specificity toward the binding site, linked with diverse molecular fragments via its O5 or O6 oxygen atom. Suitable fragments are selected with the use of 3D searches of molecular fragments library against two distinct pharmacophores designed on the basis of available structural data for aminoglycoside-RNA complexes. The compounds resulting from fragments assembly with neamine are then scored with a 3D-QSAR model developed using the biological data for known aminoglycoside derivatives. Twenty-one new potential ligands are obtained, four of which have predicted activities comparable to less potent aminoglycoside antibiotics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19434840      PMCID: PMC2772172          DOI: 10.1021/ci800361a

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  41 in total

1.  Validation of an empirical RNA-ligand scoring function for fast flexible docking using Ribodock.

Authors:  S David Morley; Mohammad Afshar
Journal:  J Comput Aided Mol Des       Date:  2004-03       Impact factor: 3.686

2.  A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.

Authors:  Nicolas Foloppe; I-Jen Chen; Ben Davis; Adam Hold; Dave Morley; Rob Howes
Journal:  Bioorg Med Chem       Date:  2004-03-01       Impact factor: 3.641

3.  Deciphering the origins of observed heat capacity changes for aminoglycoside binding to prokaryotic and eukaryotic ribosomal RNA a-sites: a calorimetric, computational, and osmotic stress study.

Authors:  Christopher M Barbieri; Annankoil R Srinivasan; Daniel S Pilch
Journal:  J Am Chem Soc       Date:  2004-11-10       Impact factor: 15.419

4.  ZINC--a free database of commercially available compounds for virtual screening.

Authors:  John J Irwin; Brian K Shoichet
Journal:  J Chem Inf Model       Date:  2005 Jan-Feb       Impact factor: 4.956

5.  Novel 2,5-dideoxystreptamine derivatives targeting the ribosomal decoding site RNA.

Authors:  Dionisios Vourloumis; Masayuki Takahashi; Geoffrey C Winters; Klaus B Simonsen; Benjamin K Ayida; Sofia Barluenga; Seema Qamar; Sarah Shandrick; Qiang Zhao; Thomas Hermann
Journal:  Bioorg Med Chem Lett       Date:  2002-12-02       Impact factor: 2.823

6.  Binding of neomycin-class aminoglycoside antibiotics to mutant ribosomes with alterations in the A site of 16S rRNA.

Authors:  Sven N Hobbie; Peter Pfister; Christian Bruell; Peter Sander; Boris François; Eric Westhof; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

7.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

8.  Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide.

Authors:  Quentin Vicens; Eric Westhof
Journal:  J Mol Biol       Date:  2003-02-28       Impact factor: 5.469

9.  Crystal structure of a complex between the aminoglycoside tobramycin and an oligonucleotide containing the ribosomal decoding a site.

Authors:  Quentin Vicens; Eric Westhof
Journal:  Chem Biol       Date:  2002-06

10.  Rational design of azepane-glycoside antibiotics targeting the bacterial ribosome.

Authors:  Sofia Barluenga; Klaus B Simonsen; Ethel S Littlefield; Benjamin K Ayida; Dionisios Vourloumis; Geoffrey C Winters; Masayuki Takahashi; Sarah Shandrick; Qiang Zhao; Qing Han; Thomas Hermann
Journal:  Bioorg Med Chem Lett       Date:  2004-02-09       Impact factor: 2.823

View more
  6 in total

1.  Driving factors in amiloride recognition of HIV RNA targets.

Authors:  Neeraj N Patwardhan; Zhengguo Cai; Aline Umuhire Juru; Amanda E Hargrove
Journal:  Org Biomol Chem       Date:  2019-10-30       Impact factor: 3.876

Review 2.  Methods to enable the design of bioactive small molecules targeting RNA.

Authors:  Matthew D Disney; Ilyas Yildirim; Jessica L Childs-Disney
Journal:  Org Biomol Chem       Date:  2014-02-21       Impact factor: 3.876

Review 3.  Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections.

Authors:  Kristin J Labby; Sylvie Garneau-Tsodikova
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

4.  Structural basis for the diversity of the mechanism of nucleotide hydrolysis by the aminoglycoside-2''-phosphotransferases.

Authors:  Clyde A Smith; Marta Toth; Nichole K Stewart; Lauren Maltz; Sergei B Vakulenko
Journal:  Acta Crystallogr D Struct Biol       Date:  2019-11-29       Impact factor: 7.652

5.  Molecular structures enumeration and virtual screening in the chemical space with RetroPath2.0.

Authors:  Mathilde Koch; Thomas Duigou; Pablo Carbonell; Jean-Loup Faulon
Journal:  J Cheminform       Date:  2017-12-19       Impact factor: 5.514

6.  Quantitative Structure-Activity Relationship (QSAR) Study Predicts Small-Molecule Binding to RNA Structure.

Authors:  Zhengguo Cai; Martina Zafferani; Olanrewaju M Akande; Amanda E Hargrove
Journal:  J Med Chem       Date:  2022-05-06       Impact factor: 8.039

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.